KalVista Pharmaceuticals, Inc.
KALVDelisted Jun 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348911
KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding KalVista Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 94 | 1 | 91 | −2 |
| Shares | 25.6M | 13.5K | 34.6M | +8.97M (+35.0%) |
| Value | $372.0M | $195.9K | $236.2M | −$135.6M (−36.5%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| TCG Crossover Management, LLC | 3,395,495 | $23.0M | 4.05% |
| VR Adviser, LLC | 2,916,667 | $19.7M | 3.32% |
| Jefferies Financial Group Inc. | 1,200,000 | $8.11M | 0.14% |
| Saturn V Capital Management LLC | 719,937 | $6.70M | 5.56% |
| Opaleye Management Inc. | 923,200 | $6.24M | 2.17% |
| Susquehanna International Group, LLP | 107,245 | $725.0K | 0.00% |
| AQR Capital Management LLC | 94,284 | $637.4K | 0.00% |
| Cheyne Capital Management (UK) LLP | 52,790 | $356.9K | 0.63% |
| PDT Partners, LLC | 47,044 | $318.0K | 0.05% |
| Panagora Asset Management Inc | 18,868 | $127.5K | 0.00% |
| Marshall Wace, LLP | 18,396 | $124.4K | 0.00% |
| Two Sigma Investments, LP | 17,416 | $117.7K | 0.00% |
| Caption Management, LLC | 17,139 | $115.9K | 0.02% |
| Jane Street Group, LLC | 15,498 | $104.8K | 0.00% |
| Thrivent Financial for Lutherans | 13,623 | $92.0K | 0.00% |
| Dynamic Technology Lab Private Ltd | 13,113 | $89.0K | 0.01% |
| Ergoteles LLC | 12,863 | $87.0K | 0.00% |
| Invesco Ltd. | 11,218 | $75.8K | 0.00% |
| Denali Advisors LLC | 10,800 | $73.0K | 0.03% |
| Nisa Investment Advisors, LLC | 3,099 | $21.0K | 0.00% |
| Group One Trading, L.P. | 897 | $6.06K | 0.00% |
| Sofos Investments, Inc. | 7 | $8 | 0.00% |
Sold out (24)
Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Deep Track Capital, LP | 1,824,000 | $26.5M |
| OrbiMed Advisors LLC | 1,042,000 | $15.1M |
| Wellington Management Group LLP | 776,510 | $11.3M |
| International Biotechnology Trust PLC | 316,133 | $4.59M |
| Point72 Asset Management, L.P. | 57,800 | $839.0K |
| New York Life Investments Alternatives | 37,784 | $548.0K |
| Gsa Capital Partners LLP | 17,236 | $250.0K |
| Walleye Trading LLC | 16,301 | $237.0K |
| Alps Advisors Inc | 13,433 | $195.0K |
| Jump Financial, LLC | 12,200 | $177.0K |
| Aristides Capital LLC | 12,000 | $174.0K |
| Cubist Systematic Strategies, LLC | 11,627 | $169.0K |
| Manufacturers Life Insurance Company, The | 10,156 | $147.4K |
| Mirae Asset Global Investments Co., Ltd. | 10,014 | $145.0K |
| Alpine Global Management, LLC | 10,000 | $145.0K |
| US Bancorp | 2,984 | $43.0K |
| Signaturefd, LLC | 548 | $8.00K |
| TCI Wealth Advisors, Inc. | 360 | $5.00K |
| China Universal Asset Management Co., Ltd. | 230 | $3.00K |
| Daiwa Securities Group Inc. | 46 | $1.00K |
| Lindbrook Capital, LLC | 42 | $1.00K |
| Ellevest, Inc. | 10 | $0 |
| Quadrant Capital Group LLC | 27 | $0 |
| Covestor Ltd | 15 | $0 |
Not filed for Q4 2022 yet (1)
Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Jefferies Group LLC | 13,500 | $195.9K |